Harnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS
|
|
- Ralph Patrick
- 5 years ago
- Views:
Transcription
1 Harnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS
2 Objectives Identify innovative ways in which the DNP can utilize their training and special interests to impact positive health care outcomes. Recognize the direct application of the DNP training and skills in various clinical settings while advancing the delivery of healthcare. Identify the critical roles the DNP fills as a transformational leader, a change agent in translating evidence to the bedside, and in the delivery of clinical excellence.
3 It is not just Academics but the Journey that Defines Us BSN MN, ARNP DNP
4 Doctors of Nursing Practice Meeting the Nation s Health Care Needs Leadership Practice Inquiry Advanced Practice
5 Responsibility to Meet Quality Standards Six Dimensions of Quality Healthcare AcrosstheChasmSixAimsforChangingtheHealthCareSystem.aspx
6 The DNP in Action Swedish Tobacco Related Diseases and Lung Cancer Screening Program
7 Annual Mortality from Tobacco Related Diseases One of every 5 deaths are tobacco related One of every 3 cancers are tobacco related Life expectancy for smokers is at least 10 years shorter than for those who are never smokers Smoking causes 90% of all lung cancers
8 Lung Cancer is the Leading Cause of Cancer Related Mortality
9 The Power of Research International Early Lung Cancer Action Program (IELCAP) 80% 10 year survival with low dose CT scan National Lung Screening Trial (NLST) 20% reduction in lung cancer mortality 6.7% reduction in all cause mortality National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lungcancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5): International Early Lung Cancer Action Program I, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):
10 Scientific Evidence Emerges into Clinical Care United States Preventive Services Task Force delivers a Grade B recommendation for lung cancer screening in high risk persons. Ages Currently smoking or quit in past 15 years Minimum 30 pack year history of smoking Affordable Care Act mandates coverage for Grade A and B USPSTF recommendations CMS returned a favorable National Coverage Determination 10 million Americans qualify for this screening
11 Screening Saves Lives Before low dose CT screening 15% were alive in 5 years With the benefit of low dose CT screening 80% were alive in 10 years
12 Coping with False Positive Findings 24% to 30% of all screened will have abnormality/ lung nodules (false positive) Only 2% to 3% of those nodules will be malignant 96.4% of those nodules will be benign This clinical scenario can cause significant psychological distress and anxiety
13 Addressing Smoking Cessation Annual Quit Data 70% want to quit 52% make a quit attempt every year 3% are successful quitting on their own Benefit of Multi-Modal Therapy 3% quit on advice alone 10% with counseling % with counseling, medication treatment, and clinical follow-up CDC, Quitting smoking among adults - United States, Morb Mortal Wkly Rep 2011; 60: Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004, 99: 29-38
14 Essentials to Screening Safely and Responsibly Adherence to eligibility criteria Adherence to shared decision making encounter Radiology component has to be in place Adherence to nodule management guidelines is essential Counsel to avoid anxiety Ensure NO nodule is left behind! Multidisciplinary clinical team oversight Address smoking cessation
15 A Program is Born Swedish Tobacco Related Diseases and Lung Cancer Screening Program Tobacco Related Diseases Evaluation Low CT scan and counseling Tobacco cessation counseling and treatment with follow-up
16 Case Study 75 year old female with 50 pack year history of smoking Quit 13 years ago In good health, works part time and travels frequently First baseline low dose CT scan in 2013
17 Nodule #1, mm Right Middle Lobe
18 Nodule #1, mm Right Middle Lobe, Unchanged
19 Nodule #1, mm Right Middle Lobe, Unchanged
20 Nodule #2, mm Right Lower Lobe
21 Nodule #2, mm Right Lower Lobe, Unchanged
22 Nodule #2, mm Right Lower Lobe, Unchanged
23 Nodule #3, mm x 4.5mm Right Lower Lobe
24 Nodule #3, mm x 4.5mm Right Lower Lobe, Unchanged
25 Nodule #3, mm x 9mm Right Lower Lobe, Changed!
26 Clinical Outcome Underwent right lower lobe wedge resection Hospitalization for 24 hours Diagnosed with a Stage I lung cancer Cured of lung cancer with no need for adjuvant chemotherapy or radiation Will continue under surveillance by low dose CT scan
27 Tobacco Related Diseases and Lung Cancer Screening Program Statistics % monthly growth (n=305) Early stage lung cancers detected = 8 Late stage lung cancer detected= 1 Metastatic pancreatic cancer detected=1 Tobacco related diseases detected 63% with CAD 38% with emphysema 8% with aortic dilation or aneurysm Smoking cessation 60% of those smoking on initial assessment have quit smoking on follow-up visit
28 Complimentary Clinical Programs Incidental Pulmonary Nodule Clinic TeleLung and TeleTobacco Center for Nicotine Dependence
29 We Don t Succeed Alone Collaboration is essential for change and a critical competency for achieving and sustaining high performance.
30 Transformational Leadership and Collaborative Partnerships
31 Collaboration Calls for Convergence of Professions Quality and Patient Centered Care
32 Critical Elements of a Collaborative Partnership Communicate and Build Cohesion Create Shared Vision and Purpose Encourage Diversity by Including all Members Develop Trusting Relationships Kouzes, J. M., & Posner, B. Z. (2007). The leadership challenge (4th ed.)
33 Create Shared Vision and Purpose Shared goals A collective focus bonds people/teams Shared goals give reason to be together
34 Communication and Cohesion Communicate openly, often, and face-to-face Include everyone on the team Err on the side of over communicating Fix things when communication goes wrong
35 Encourage Diversity Include everyone Diversity creates synergy Learn from others
36 Develop Trusting Relationships A team is defined by working with others People have to rely on others The heart of collaboration is trust You can t get extraordinary things done without trust Trust begets trust
37 Working in Collaborative Partnerships We Can
38 Innovating on the Front Lines of Clinical Health Care: You Can Do It! Identify a clinical need Conduct a needs assessment Evaluate best clinical practices Survey existing evidence Identify and consult with stakeholders Translate evidence to clinical care with programmatic elements Collaborate with others every step of the way Set your goals high, and plan proactively Don t forget that people are looking to you for leadership
39 Visualize the DNP in YOU! Clinician Leader Educator Researcher Author
40 Alone we can do so little; together we can do so much. Helen Keller
41 Thank you very much!
CT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationLung Cancer Screening
Lung Cancer Screening Preston Wright, DO University of Kansas School of Medicine- Wichita Family Medicine Residency at Via Christi Hospitals 1 Objectives Identify patients who need screened for lung cancer
More informationLung Cancer Screening: To screen or not to screen?
Lung Cancer Screening: To screen or not to screen? Dan J. Raz, M.D. Co Director, Lung Cancer Screening Program Co Director, LungCancer and Thoracic OncologyProgram Assistant Professor, Thoracic Surgery
More informationLung Cancer Screening:
Lung Cancer Screening: Maximizing Gain and Dealing with Pandora s Box Mark M. Fuster, MD Division of Pulmonary & Critical Care UCSD Department of Medicine & VA San Diego Healthcare Service San Diego, CA
More informationVeterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned
Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned Jane Kim, MD, MPH Acting Chief Consultant for Preventive Medicine National Center for Health Promotion
More informationLDCT Screening. Steven Kirtland, MD. Virginia Mason Medical Center February 27, 2015
LDCT Screening Steven Kirtland, MD Virginia Mason Medical Center February 27, 2015 2 Disclosures 4 5 Cancer Screening Mrs H 64yo 50 pk year smoker Lung Cancer Epidemiology Leading Cause of Cancer Death
More informationLung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health
Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding
More informationMeasure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use
Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use 2010 PQRI REPTING OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients aged 18 years or older who
More informationLung Cancer Screening. Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017
Lung Cancer Screening Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017 Nearly one in six American adults currently smoke cigarettes An estimated 40 million adults in the United
More informationA Comprehensive Cancer Center Designated by the National Cancer Institute
N C I C C C A Comprehensive Cancer Center Designated by the National Cancer Institute Screening and Early Detection of Lung Cancer: Ready for Practice? David S. Ettinger, MD, FACP, FCCP Alex Grass Professor
More informationScreening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering
Screening Programs background and clinical implementation Denise R. Aberle, MD Professor of Radiology and Engineering disclosures I have no disclosures. I have no conflicts of interest relevant to this
More informationLung Cancer Screening
Lung Cancer Screening Steven Leh, MD, FCCP Diplomat of the American Association for Bronchology and Interventional Pulmonology Aurora Medical Group Pulmonary and Sleep Medicine February 10, 2018 Disclosures
More informationCriteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer
Lung Cancer Screening Guidelines with low- dose computed tomography (LDCT): USPSTF and CMS February 6, 2015 Kentucky Cancer Consortium and Kentucky LEADS Component 3 Jennifer Redmond Knight, DrPH, jredknight@kycancerc.org
More informationChristine Argento, MD Interventional Pulmonology Emory University
Christine Argento, MD Interventional Pulmonology Emory University Outline Lung Cancer Statistics Prior Studies for Lung Cancer Screening NLST Studies Following NLST Future Directions Lung Cancer American
More informationLung Cancer Screening: Current Status
Lung Cancer Screening: Current Status I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of investigational or off-label use of a product
More informationSHARED DECISION MAKING IN MEDICARE COVERAGE
SHARED DECISION MAKING IN MEDICARE COVERAGE Kate Goodrich, MD MHS Director, Center for Clinical Standards and Quality CMS April 2, 2016 Disclaimer: Views and comments in this presentation are those of
More informationSHARED DECISION MAKING AND LUNG CANCER SCREENING
SHARED DECISION MAKING AND LUNG CANCER SCREENING DISCLOSURES Cathleen E. Morrow, MD None William C. Black, MD No financial disclosure Co-investigator for NLST Member of the ACR Lung-RADS Screening Registry
More informationDisclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures
Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional
More informationGoals of Presentation
Goals of Presentation Review context of lung cancer screening why is it important? Review data from NLST supporting screening with lowdose CT (LDCT) scanning Discuss the pros and cons of LDCT screening
More information2017 Annual Report CANCER CENTER
2017 Annual Report CANCER CENTER New Lung Cancer Cases-2016 Lung cancer is the leading cause of cancer deaths, among both men and women, in the United States - claiming more lives each year than colon,
More informationLung Cancer Screening: Benefits and limitations to its Implementation
Lung Cancer Screening: Benefits and limitations to its Implementation Rolando Sanchez, MD Clinical Assistant Professor Pulmonary-Critical Care Medicine University of Iowa Lung cancer - Epidemiology Cancer
More informationThe complex, intertwined role of patients in research and care
Session 3: The complex, intertwined role of patients in research and care Joseph Chin, MD, MS, Acting Deputy Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services The complex,
More informationEquity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA
Equity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA Mary Pasquinelli, MS, APRN, FNP-BC Pulmonary and Thoracic Medical Oncology Director,
More informationLung Cancer Screening
Lung Cancer Screening Mission Health Poised to Usher in New Era of Hope for Lung Cancer Patients Everyone in western North Carolina deserves the best care possible the patient at high risk for lung cancer,
More informationFaculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky
Lung Cancer in Kentucky: Improving Patient Outcomes Faculty Disclosure The presenter and members of the development team do not have any conflicts to report. Celeste T. Worth, MCHES Kentucky Collaborative
More information2015 Annual Report Lung Screening
05 Annual Report Lung Screening Flaget Cancer Center Monte Martin, MD Joseph Shaughnessy, MD CANCER SERVICES PROGRAM From the Director We are pleased to share with you the Lung Cancer Report for 05. With
More informationAHEC Tobacco Online Modules
AHEC Tobacco Online Modules www.aheceducation.com This program is sponsored by the Florida AHEC Network and the Florida Department of Health. In July 2007, the Florida legislature appropriated funds to
More informationDOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS
DOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS December 2018 Page 1 of 18 Document Title: Document Ref. Number: DOH Lung Cancer Screening Service Specifications PH/NCD/LCSC/SR/0.9 Version: 0.9 Approval
More informationDiagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017
Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations
More informationAchieving the Goals of the National Cancer Moonshot through Adoption of New and Enhanced Technologies and a Transformed IT Health System
The National Photonics Initiative presents: Achieving the Goals of the National Cancer Moonshot through Adoption of New and Enhanced Technologies and a Transformed IT Health System Thursday, June 30 at
More informationFrequently Asked Questions for Clinicians For screening of lung cancer in high-risk patients
Frequently Asked Questions for Clinicians For screening of lung cancer in high-risk patients What is EarlyCDT Lung? EarlyCDT Lung is a simple, affordable blood test for the early detection of lung cancer.
More informationObjectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival
Objectives Appraise lung cancer screening trials results Review screening guidelines Lung Cancer Screening: Past, Present and Future Chi Wan Koo, MD Koo.chiwan@mayo.edu Discuss recommendations essential
More informationSCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art
SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art Reginald F. Munden MD, DMD, MBA I have no conflicts of interest to report National Lung Cancer Screening Trial 20% lung cancer mortality
More informationAn Update on Lung Cancer Screening Policy and the Role of Quitlines
An Update on Lung Cancer Screening Policy and the Role of Quitlines Robert J. Volk, PhD Vance Rabius, PhD The University of Texas MD Anderson Cancer Center North American Quitline Consortium NAQC Conference
More informationLUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC
: THE TIME HAS COME Physician Leader, Lung Cancer Multi-Disciplinary Program Fletcher Allen Health Care Annual Meeting Montpelier, VT - April 25, 2014 Gerald S. Davis, MD Professor of Medicine University
More informationOrganization: NAMI Minnesota Request ID: Program Title: Reducing Smoking Among People with Mental Illnesses
Organization: NAMI Minnesota Request ID: 16872475 Program Title: Reducing Smoking Among People with Mental Illnesses 1. Overall Goal & Objectives The overall goal of this project is to reduce the rate
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationAmerican Medical Association Journal of Ethics
American Medical Association Journal of Ethics July 2015, Volume 17, Number 7: 601-607 ETHICS CASE Close-Call Screening and Shared Decision Making Commentary by Evelyn Chan, MD, MS Dr. Samuelson is an
More informationRole of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D.
Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D. Lung Cancer 219,440 new cases/year in U.S. (2009) 169,390 deaths/year in U.S. mortality greater than from breast, colon, prostate CA combined
More informationNational Lung Screening Trial Results
National Lung Screening Trial Results Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan NLST STOPPED! Lung cancer trial results
More informationNational Cancer Programme. Work Plan 2015/16
National Cancer Programme Work Plan 2015/16 Citation: Ministry of Health. 2015. National Cancer Programme: Work plan 2015/16. Wellington: Ministry of Health. Published in October 2015 by the Ministry of
More informationCT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite
CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center November 2018 2016 data, 3 years after ACS recommendation
More informationSCREENING FOR EARLY LUNG CANCER. Pang Yong Kek
SCREENING FOR EARLY LUNG CANCER Pang Yong Kek Lecture Outline Why performing screening? How to improve early detection? Benefits and Risks of screening Challenges in screening Conclusion Why Performing
More informationTWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION
Appendix G PHASE OF MANAGEMENT NOTIFICATION ASSESSMENT TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION ACTIONS All patients will be advised on admission that :
More informationLung Cancer Screening: To Screen or Not to Screen?
Lung Cancer Screening: To Screen or Not to Screen? Lorriana Leard, MD Co-Director of UCSF Lung Cancer Screening Program Vice Chief of Clinical Activities UCSF Pulmonary, Critical Care, Allergy & Sleep
More informationNCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening
444 Original Research NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening Brady J. McKee, MD; Shawn Regis, PhD; Andrea K. Borondy-Kitts, MS, MPH; Jeffrey A. Hashim, MD; Robert J.
More informationThe National Lung Screening Trial (NLST)
The National Lung Screening Trial (NLST) Pamela Marcus US National Cancer Institute May 21, 2012 Today s talk NLST: an overview Typical challenges in cancer screening RCTs Starting ti a trial in the presence
More informationCLINICAL GUIDELINES. Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P.
CLINICAL GUIDELINES Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P. 3/14/2015 Introduction: The purpose of a lung-cancer screening program is to detect
More informationCT Lung Screening Implementation Challenges: State Based Initiatives
CT Lung Screening Implementation Challenges: State Based Initiatives Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center Co-Director Rescue Lung, Rescue Life Program Co-Chair Massachusetts
More informationPublic Health Unit Tobacco Use Cessation Services
March 2017 Public Health Unit Tobacco Use Cessation Services Under the Ontario Public Health Standards, 1 Public Health Units (PHUs) are required to do a number of activities related to tobacco use cessation
More informationWhat to know and what to make of it
Lung Cancer Screening: What to know and what to make of it J. Matthew Reinersman, MD Assistant Professor of Surgery Division of Thoracic and Cardiovascular Surgery Department of Surgery University of Oklahoma
More informationVHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening
VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening ATS San Francisco 2016 James K. Brown MD 1, Kathryn L. Rice, MD 2 (1) San Francisco VA (2) Minneapolis VAMC Disclosures
More informationDISCLOSURE. Lung Cancer Screening: The End of the Beginning. Learning Objectives. Relevant Financial Relationship(s) Off Label Usage
Peninsula Regional Medical Center 12 th Annual Lung Cancer Conference March 9, 2017 Lung Cancer Screening: The End of the Beginning David E. Midthun M.D. Professor of Medicine College of Medicine, Mayo
More informationCharles Mulligan, MD, FACS, FCCP 26 March 2015
Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening
More informationGetting national guidelines into practice: It takes more than education
Getting national guidelines into practice: It takes more than education AI Collaborative Group 2 September 12, 2017 Lynette M. Wachholz, MN, ARNP, CPHQ Email: lwachholz@everettclinic.com The Everett Clinic
More informationAn Evaluation of the Bruce Grey Hospital-Community Smoking Cessation Program
May, 2011 An Evaluation of the Bruce Grey Hospital-Community Smoking Cessation Program Prepared for Keystone Child, Youth and Family Services & Partners By The Centre for Community Based Research www.communitybasedresearch.ca
More informationLung Cancer Screening for the Poor and Underserved: Should Routine Screening be Performed?
Elmer Press Original Article Lung Cancer Screening for the Poor and Underserved: Should Routine Screening be Performed? Vaibhav Verma a, d, Vladimir K. Gotlieb a, Joshua Fogel b, Alan S. Multz a, Geeti
More informationA Summary from the 2013World Conference on Lung Cancer Sydney, Australia
A Summary from the 2013World Conference on Lung Cancer Sydney, Australia In 2011, the U.S. National Lung Screening Trial (NLST) has demonstrated that low-dose computed tomography (LDCT) screening of high
More informationGuide to Understanding Lung Cancer
Guide to Understanding Lung Cancer Lung cancer is the second most common cancer overall for men and women in the U.S., with an estimated 222,500 new cases in 2017. However, lung cancer is the most common
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationChoosing Wisely. Objectives. Payal Sen PGY 1 Internal Medicine Residency Program University of New Mexico
Choosing Wisely Payal Sen PGY 1 Internal Medicine Residency Program University of New Mexico Financial Disclosure I have no relationships with any entity producing, marketing, reselling or distributing,
More informationLUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS?
LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? DAVID O. WILSON, MD, MHP DIRECTOR GEORGIA COOPER MEMORIAL LUNG CANCER RESEARCH REGISTRY UNIVERSITY OF PITTSBURGH
More informationOverview LHIN 4 10/4/2014. Diagnostic Assessment Programs for Lung & Esophageal Cancer. Improving the Patient Experience.
Diagnostic Assessment Programs for Lung & Esophageal Cancer Improving the Patient Experience CSGNA 2014 DR. COLIN SCHIEMAN ASSOCIATE PROFESSOR THORACIC SURGERY MCMASTER UNIVERSITY Overview Introduction
More informationISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW
ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):
More informationSmoking Rates and Tobacco Cessation Coverage in Medicaid Expansion
Smoking Rates and Tobacco Cessation Coverage in Medicaid Expansion On December 8, 2016, State Medicaid Expansion Tobacco Cessation Coverage and Number of Adult Smokers Enrolled in Expansion Coverage United
More informationLung Cancer Screening Benefits, Risks & Challenges
Lung Cancer Screening Benefits, Risks & Challenges Polly Sather, APRN Yale Lung Screening and Nodule Program (Yale Lung SCAN) A Multidisciplinary Comprehensive Initiative Yale Cancer Center Thoracic Oncology
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More information10/17/16. Lung Cancer Screening. Question 1: Does lung cancer screening make sense? 3rd lung cancer third most prevalent tumor type
Lung Cancer Screening Greg Rogalski Mercy Radiology Group greg@grogo.org Question 1: Does lung cancer screening make sense? 2 Requirements for successful screening process Sufficiently high prevalence
More informationThe Maine Lung Cancer Coalition. Working Together to Reduce Lung Cancer in Maine
The Maine Lung Cancer Coalition Working Together to Reduce Lung Cancer in Maine funding Maine Lung Cancer Coalition (MLCC) Webinar Insurance Coverage For Low Dose CT Lung Screenings with Barbara Wiggin,
More informationState of Behavioral Health. The Arizona Initiative for Tobacco Free Living in Individuals with Behavioral Health Disorders
Helping People with Mental Health Issues Live Longer Lives without Tobacco The Arizona Initiative for Tobacco Free Living in Individuals with Behavioral Health Disorders Stephen S. Michael, MS Director,
More informationNone
2014 None rosemary clooney Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common
More informationTHE BENEFITS OF BIG DATA
THE BENEFITS OF BIG DATA Disclosures I am a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on CT scans of the chest which are owned by Cornell
More informationNational Cancer Programme. Work Plan 2014/15
National Cancer Programme Work Plan 2014/15 Citation: Ministry of Health. 2014. National Cancer Programme: Work Plan 2014/15. Wellington: Ministry of Health. Published in December 2014 by the Ministry
More informationMarch 26, The Honorable Richard Durbin United States Senate 332 Dirksen Senate Office Building Washington, DC Dear Senator Durbin:
March 26, 2001 The Honorable Richard Durbin United States Senate 332 Dirksen Senate Office Building Washington, DC 20510 Dear Senator Durbin: ENACT, a coalition of more than 60 national organizations dedicated
More informationACA first-dollar coverage for preventive services
I N F O R M A T I O N U P D A T E September 2014 ACA first-dollar coverage for preventive services The Affordable Care Act (ACA) mandates that all non-grandfathered group and individual health plans must
More informationWhat is Quitline Iowa?
CONTENTS: What is Quitline Iowa? 0 A telephone counseling helpline for tobacco-use cessation. Free to all residents of the state of Iowa Open Monday-Thursday 7:00am 12:00am / Friday 7:00am 9:00pm / Saturday
More informationSusan J. Curry, Ph.D. Chairperson U.S. Preventive Services Task Force 5600 Fishers Lane Mail Stop 06E53A Rockville, MD 20857
National Board of Directors Chair John F. Emanuel, JD Secretary/Treasurer Stephen R. O Kane Past Chair Kathryn A. Forbes, CPA Directors Linn P. Billingsley, BSN Larry Blumenthal Michael F. Busk, MD, MPH
More informationYou Can Make a Difference!
You Can Make a Difference! How to help your clients become tobacco free What Does Smoking Cost Us? One study estimates that cost savings of between $1,142 and $1,358 per pregnancy can be achieved for each
More informationand Strength of Recommendations
ASTRO with ASCO Qualifying Statements in Bold Italics s patients with T1-2, N0 non-small cell lung cancer who are medically operable? 1A: Patients with stage I NSCLC should be evaluated by a thoracic surgeon,
More informationCT Low Dose Lung Cancer Screening. Part I. Journey to LDCT LCS Program
CT Low Dose Lung Cancer Screening Part I Journey to LDCT LCS Program Paul Johnson, M.S., DABHP, DABR Cleveland Clinic September 26, 2015 Lung Caner is No. 1 In Cancer Related Death In The United States
More informationAbdominal Aortic Aneurysm
Abdominal Aortic Aneurysm David N. Duddleston, MD VP and Medical Director Southern Farm Bureau Life Jackson, Mississippi A Case Ms. Ima Bolgin,, age 54, $1.2 million, sent to you for review. Smoker, ½
More informationMay-Lin Wilgus. A. Study Purpose and Rationale
Utility of a Computer-Aided Diagnosis Program in the Evaluation of Solitary Pulmonary Nodules Detected on Computed Tomography Scans: A Prospective Observational Study May-Lin Wilgus A. Study Purpose and
More informationA systems approach to treating tobacco use and dependence
A systems approach to treating tobacco use and dependence Ann Wendland, MSL Policy Analyst & Cessation Programs Manager NYSDOH Bureau of Tobacco Control ann.wendland@health.ny.gov A systems approach to
More informationLow-Dose CT Cancer Screening Program
Low-Dose CT Cancer Screening Program 1 History of Low-Dose CT Screening In 2011, the National Lung Screening Trial (NLST) was the first trial that provided evidence based support that Low-Dose CT (LDCT)
More informationLung Cancer Screening: Evidence and current recommendations
Lung Cancer Screening: Evidence and current recommendations 20 th March 2018 Dr Annette McWilliams Fiona Stanley Hospital University of Western Australia WA Cancer & Palliative Care Network I have no financial
More informationThe status of Lung Cancer Screening Guidelines. Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center
The status of Lung Cancer Screening Guidelines Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center bachp@mskcc.org @peterbachmd Homogeneity of guidelines But what about these? Outside the box
More informationWill CT screening reduce overall lung cancer mortality? Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH
Will CT screening reduce overall lung cancer mortality? Heidi Roberts MD FRCP(C) Heidi Roberts, MD, FRCP(C) Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH Screening - Requirements
More informationLung Cancer screening :
Lung Cancer screening : Pro-Contra SAMO interdisciplinary workshop on chest tumors 27 and 28 january 2017 Prof L.P.Nicod Sevice de pneumologie CHUV-Lausanne -CH Lung Cancer How big is the problem? Epidemiology
More information2017 CANCER ANNUAL REPORT
2017 CANCER ANNUAL REPORT A WORD FROM OUR LEADERSHIP We are pleased to present our 2017 Annual Report highlighting advances in state of the art cancer care at the Roper St. Francis Cancer Program. Our
More informationScreening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center
Screening for Lung Cancer Michael S. Nolledo, MD Deborah Heart and Lung Center 1 1 Outline Ø Introduction Ø Lung Cancer Screening pre-2010 Ø Lung Cancer Screening today 2 2 Lung Cancer 2011 (Siegel et
More informationThe Quit Clinic As an Anti-smoking Advocacy Tool
The Quit Clinic As an Anti-smoking Advocacy Tool Associate Professor Chanchai Sittipunt MD Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Faculty of Medicine Chulalongkorn
More informationLUNGS? YOU GET THESE YOUR GUIDE TO YEARLY LUNG CANCER SCREENING CHECKED REGULARLY. WHAT ABOUT YOUR. Think. Screen. Know.
YOU GET THESE CHECKED REGULARLY. WHAT ABOUT YOUR LUNGS? YOUR GUIDE TO YEARLY LUNG CANCER SCREENING WHAT YOU SHOULD KNOW BEFORE, DURING, AND AFTER Think. Screen. Know. Talk to your doctor. TABLE OF CONTENTS
More information2015 Annual Report Lung Cancer Screening
2015 Annual Report Lung Cancer Screening Cancer and Blood Specialists (from left to right): Mohammad Iltaf Khan, MD, PhD; Christopher C. Croot, MD; Khuda Dad Khan, MD, PhD; Vijay Raghavan, MD; Subhash
More informationLearning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening
Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context
More informationLung Cancer Screening: Now What?
Lung Cancer Screening: Now What? Gerold Bepler, M.D., Ph.D. Director, President & CEO Michigan Cancer Consortium, 2013 Annual Meeting, Lansing, MI, 11/20/13 Lung Cancer #1 Cause of Cancer Death for & *
More informationLinking Public Interests to Ensure Sustainable Statewide Quitlines
Linking Public Interests to Ensure Sustainable Statewide Quitlines Public health tobacco prevention and control programs (TCPs) find themselves working within evershifting financial and political landscapes,
More informationCSQI BACKGROUNDER What is The Cancer Quality Council of Ontario (CQCO)? What does CQCO do? What is the Cancer System Quality Index?
CSQI BACKGROUNDER What is The Cancer Quality Council of Ontario (CQCO)? Established in 2002 by the Ministry of Health and Long-Term Care (MOHLTC), the Cancer Quality Council of Ontario (CQCO) is an arm
More informationPANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD
PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University Objectives 1.
More informationprivate patients centre stop smoking clinic Royal Brompton Hospital London
private patients centre stop smoking clinic Royal Brompton Hospital London Royal Brompton and Harefield Contents 3 Smoking kills 4 There are many benefits of giving up 5 It is never too late to stop 7
More informationTobacco Free Hospitals
Tobacco Free Hospitals Improving the Health of the Community Tom Peterson, M.D. Disclosure Tom Peterson, MD, is on the speaker s bureau of Pfizer, Inc. Learning Objectives Define a smoke-free hospital
More information